Profile
AERI ZTS HLN TAK TEVA ITCI
Company Name Aerie Pharmaceuticals, Inc. Zoetis Inc. Haleon plc Takeda Pharmaceutical Company Limited Teva Pharmaceutical Industries Limited Intra-Cellular Therapies, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic
Market Cap - $70.23B $48.53B $47.75B $20.71B $14.05B
Employees 0.38K 13.80K 24.56K 49.28K 33.89K 0.86K
CEO Dr. Vicente Anido Ms. Kristin C. Peck Mr. Brian James McNamara Mr. Christophe Weber Mr. Richard D. Francis Dr. Sharon Mates Ph.D.
Ratings
Trading
AERI ZTS HLN TAK TEVA ITCI
Last Close $15.25 $161.69 $10.57 $14.27 $18.07 $131.87
High 52 $15.25 $196.48 $10.77 $15.37 $22.77 $131.91
Low 52 $15.25 $144.45 $8.24 $12.6 $12.82 $64.96
Price vs. 52 Week High 0 % -17.71 % -1.86 % -7.16 % -20.64 % -0.03 %
Price vs. 52 Week Low 0 % 11.93 % 28.28 % 13.25 % 40.95 % 103 %
Total Return
AERI ZTS HLN TAK TEVA ITCI
1 Month Return 0 % 5.25 % 9.48 % -0.55 % 27.61 % 0 %
3 Month Return 0 % -5.68 % 10.68 % 5.47 % 7.24 % 3.83 %
6 Month Return 0 % -8.56 % 9.99 % 3.56 % 5.61 % 44.45 %
9 Month Return 0 % -12.72 % 7.75 % 2.88 % 3.67 % 79.15 %
YTD Return 0 % -0.76 % 10.8 % 7.78 % -18.01 % 57.89 %
1 Year Return 0 % -3.83 % 27.97 % 6.73 % 12.94 % 101.14 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
AERI ZTS HLN TAK TEVA ITCI
Dividend Yield Percentage (TTM) - 1.18 % 0.02 % 4.58 % - -
Dividend Paid and Capex Coverage Ration (TTM) -30.13 % 2.05 % - 1.76 % 2.5 % -227.26 %
Dividend Per Share (TTM) - 1.86 % 0.07 % 196 % - -
Payout Ratio (TTM) - 31.62 % - 145.09 % - -
Growth
AERI ZTS HLN TAK TEVA ITCI
Asset Growth 7.3 % 8.25 % -9.55 % 87.69 %
Gross Profit Growth 189.4 % 1.76 % 5.47 % 44.88 %
Revenue Growth 133.51 % 5.87 % 4.4 % 46.62 %
Revenue 3 Year 621.88 % 33.13 % 1.52 % 556.51 %
Revenue 5 Year - 103.83 % -5.5 % 600974.32 %
Revenue 10 Year - 152.69 % -38.45 % 32663.23 %
EBIT Growth 70.9 % -64.98 % -169.63 % 26.77 %
Net Income Growth 59.14 % -54.56 % -193.2 % 46.54 %
Net Income 3 Yeari Growth Per Share 71.08 % -61.74 % -482.97 % 79.29 %
Net Income 5 Yeari Growth Per Share 52.51 % 32.36 % -58.26 % 72.95 %
Net Income 10 Yeari Growth Per Share -97.3 % 35.42 % -140.46 % 32.41 %
Operating Income Growth 70.9 % -56.36 % -169.98 % 26.77 %
Operating Cash Flow Growth (CFG) -53.28 % -26.69 % -8.85 % 41.08 %
Operating 3 Year CFG 41.57 % -29.25 % 52.26 % 77.79 %
Operating 5 Year CFG 21.91 % 118.64 % 123.59 % 69.4 %
Operating 10 Year CFG -182.62 % 384.17 % -81.66 % 10.87 %
EPS Growth 59.65 % -54.92 % -190 % 50.68 %
EPS Diluted Growth 59.65 % -54.86 % -190 % 50.68 %
Book Value Per Share -171.63 % 13.54 % -30.36 % 80.54 %
Share Holder 3 Year Equity Growth Per Share -106.84 % 40.38 % -49 % 116.52 %
Share Holder 5 Year Equity Growth Per Share -110.35 % 41.33 % -62.86 % 215.14 %
Share Holder 10 Year Equity Growth Per Share -150.88 % 195.14 % -82.6 % 164.65 %
Dividend Per Share Growth - 1.95 % - -
Dividend 3 Year Growth Per Share - 1.19 % - -
Dividend 5 Year Growth Per Share - 101.42 % -100 % -
Dividend 10 Year Growth Per Share - 102.58 % -100 % -
Debt Growth 21.06 % 10.53 % -10.29 % 0.25 %
Free Cash Flow Growth -51.12 % -31.4 % -11.05 % 40.95 %
Updated On 31 Dec 2021 31 Mar 2024 31 Dec 2024 31 Dec 2024
Profitability
AERI ZTS HLN TAK TEVA ITCI
Gross Profit Margin TTM 86.17 % 69.85 % 61.52 % 54.74 % 48.74 % 91.63 %
Return on Assets TTM -17.34 % 17.46 % 4.2 % 1.38 % -4.17 % -5.46 %
Return on Equity TTM -2255.01 % 49.65 % 8.73 % 2.83 % -26.15 % -7.4 %
Return on Capital Employed TTM -14.79 % 31.33 % 7.74 % 3.62 % -1.14 % -10.05 %
Net Income Per EBT TTM 100.8 % 79.35 % 75.5 % 89.75 % 127.75 % 100.64 %
EBT Per Ebit TTM 163.79 % 92.36 % 86.58 % 49.18 % 423.43 % 63.57 %
EBIT Per Revenue TTM -23.34 % 36.65 % 19.64 % 10.3 % -1.83 % -17.15 %
Cash Flow To Debt Ratio TTM -38.04 % 43.79 % - 22.2 % 6.9 % -430.93 %
Receivables Turnover TTM 1.22 7.03 5.9 6.23 5.41 4.09
Payables Turnover TTM 3.24 6.45 2.19 4.5 3.85 2.18
Inventory Turnover TTM 0.66 1.21 3.63 1.66 2.82 2.17
Fixed Asset Turnover TTM 261.84 % 256.4 % 584.75 % 226.93 % 334.34 % 4569.25 %
Asset Turnover TTM 45 % 65.01 % 32.73 % 30.31 % 42.07 % 49.79 %
Operating Cash Flow Per Share TTM -2.14 6.55 - 677.91 1.1 -0.71
Free Cash Flow Per Share TTM -2.21 5.1 - 483.45 0.66 -0.71
Cash Per Share TTM 301.71 % 440.62 % 24.05 % 33229.49 % 291.26 % 970.67 %
Operating Cash Flow Sales Ratio TTM -51.08 % 31.9 % - 23.47 % 7.54 % -10.75 %
Free Cash Flow Operating Cash Flow Ratio TTM 103.32 % 77.82 % - 71.32 % 60.06 % 100.44 %
Cash Flow Coverage Ratios TTM -38.04 % 43.79 % - 22.2 % 6.9 % -430.93 %
Price To Free Cash Flows Ratio TTM - 30.56 - 8.85 27.87 -191.12
Price To Operating Cash Flows Ratio TTM -7.13 24.02 - 6.31 16.55 -185.85
Price Cash Flow Ratio TTM -7.13 24.02 - 6.31 16.55 -185.85
Income Statement (TTM)
AERI ZTS HLN TAK TEVA ITCI
Revenue $0.19B $9.26B $11.23B $4263.76B $16.54B $0.68B
Gross Profit $0.17B $6.54B $6.95B $2832.26B $8.06B $0.62B
Gross Profit Ratio 86.2% 70.62% 61.85% 66.43% 48.74% 91.63%
EBITDA $-0.01B $3.87B $2.51B $874.6B $0.72B $-0.12B
Net Income $-0.07B $2.49B $1.44B $144.07B $-1.64B $-0.07B
EPS Diluted -1.61 5.47 0.32 45.58 -1.45 -0.72
Balance Sheet (MRQ)
AERI ZTS HLN TAK TEVA ITCI
Long Term Debt $0.26B $5.39B $8.54B $5029.93B $16B $0.01B
Total Liabilities $0.45B $9.47B $18.09B $7834.79B $33.61B $0.22B
Total Equity $-0.02B $4.77B $16.22B $7274.01B $5.73B $1.15B
Total Investments $0.1B $0B $0.08B $445.7B $0B $0.69B
Total Debt $0.26B $6.74B $10.1B $4843.75B $18.08B $0.02B
Total Assets $0.43B $14.24B $34.32B $15108.79B $39.33B $1.37B
Cash Flow Statement (TTM)
AERI ZTS HLN TAK TEVA ITCI
Net Income $-0.07B $2.5B $1.44B $144.07B $-1.96B $-0.07B
Inventory $-0.01B $-0.04B $0.22B $-115.74B $0.17B $-0.01B
Dividends Paid $0B $-0.79B $-0.57B $-287.19B $0B $0B
Operating Cash Flow $-0.1B $2.95B $2.3B $716.34B $1.25B $-0.07B
Capital Expenditure $-0B $-0.66B $-0.25B $-480.73B $-0.5B $-0B
Related Stocks
Ticker Name Price
ACB Aurora Cannabis Inc. 4.86
ACOR Acorda Therapeutics, Inc. 0.661
ACRX AcelRx Pharmaceuticals, Inc. 0.86
ADMP Adamis Pharmaceuticals Corporation 0.775
ADMS Adamas Pharmaceuticals, Inc. 8.22
AGRX Agile Therapeutics, Inc. 1.51
AKAN Akanda Corp. 1.17
ALIM Alimera Sciences, Inc. 5.54
ALVO Alvotech 9.69
ALVOW Alvotech 1.79
AMPH Amphastar Pharmaceuticals, Inc. 24.11
AMRX Amneal Pharmaceuticals, Inc. 7.42
AMYT Amryt Pharma plc 14.7
ANIP ANI Pharmaceuticals, Inc. 66.29
APUS Apimeds Pharmaceuticals US, Inc 0.00001
AQST Aquestive Therapeutics, Inc. 2.79
ASRT Assertio Holdings, Inc. 0.6101
ATNX Athenex, Inc. 0.2031
AVDL Avadel Pharmaceuticals plc 9.39
AYTU Aytu BioPharma, Inc. 1.25
ETFs With Exposure to AERI
Ticker ETF Name Weight Percentage Price
IWM iShares Russell 2000 ETF 0.03 200.84
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 123.37
IWN iShares Russell 2000 Value ETF 0.01 149.29
IWV iShares Russell 3000 ETF 0 321.38
IWO iShares Russell 2000 Growth ETF 0.05 261.53
VHT Vanguard Health Care Index Fund 0 242.71
BIB ProShares Ultra Nasdaq Biotechnology 0.03 39.68
HDG ProShares Hedge Replication ETF 0 48.808
UWM ProShares Ultra Russell2000 0.01 32.9
IWC iShares Micro-Cap ETF 0.17 114.15
FHLC Fidelity MSCI Health Care Index ETF 0.01 62.53
URTY ProShares UltraPro Russell2000 0.01 32.45
BTEC Principal Healthcare Innovators ETF 0.21 39.49
GSSC Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF 0.14 63.95
IHE iShares U.S. Pharmaceuticals ETF 0.3 63.74
AGNG Global X Aging Population ETF 0.6 30.707
PBSM Invesco PureBeta MSCI USA Small Cap ETF 0.02 31.9152
PSC Principal U.S. Small-Cap Multi-Factor ETF 0.06 49.99
VTWG Vanguard Russell 2000 Growth Index Fund 0.02 191.1
VSTCX Vanguard Strategic Small-Cap Equity Fund Investor Shares 0.05 36.36
SPGM SPDR Portfolio MSCI Global Stock Market ETF 0.01 63.75
MARB First Trust Vivaldi Merger Arbitrage ETF 1.46 20.11
IEIH iShares Evolved U.S. Innovative Healthcare ETF 0.03 34.1348
RYLD Global X Russell 2000 Covered Call ETF 0.03 14.625
AVUS Avantis U.S. Equity ETF 0 92.75
IBBQ Invesco Nasdaq Biotechnology ETF 0.07 19.495
JFWD Jacob Forward ETF 2.66 11.8807
BTEC.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.07 5.75
WSML.L iShares MSCI World Small Cap UCITS ETF 0.01 7.5205
AGED.L iShares Ageing Population UCITS ETF 0.09 7.9675
QQQS Invesco NASDAQ Future Gen 200 ETF 0.53 23.64
IUSN.DE iShares MSCI World Small Cap UCITS ETF 0.01 6.681
SXRG.DE iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced UCITS ETF USD (Acc) 0.03 438.45
VEXPX Vanguard Explorer Fd 0 106.11
WLDS.L iShares MSCI World Small Cap UCITS ETF 0.01 5.6555
VHCIX Vanguard HealthCare Index Fund Admiral Shs 0 122.77
JKK iShares Morningstar Small-Cap Growth ETF 0.02 307.42
JKJ iShares Morningstar Small-Cap ETF 0.01 231.193
LNGR Global X Aging Population ETF 0.6 27.75
JKL iShares Morningstar Small-Cap Value ETF 0.01 172.726
Unlock